Home › Therapeutic areas › Cardiovascular › Heterozygous Familial Hypercholesterolemia
Heterozygous Familial Hypercholesterolemia (1 companies)
Companies with an active program in Heterozygous Familial Hypercholesterolemia.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma | CardiovascularMetabolic+1 | 1 | NDA Submitted | $2.27B | 6 |
No companies match.